| 90677 | This code represents a vaccine product administered intramuscularly to protect against pneumococcal disease, a bacterial infection. This is a 20–valent vaccine, protecting against 20 strains of the… | 50 | $280 | $14.2K |
| 91322 | This code represents a SARS–CoV–2 vaccine product administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 50 mcg/0.5 mL. | 70 | $140 | $9.4K |
| 90662 | This code represents a flu vaccine product that is a split virus type, contains no preservatives, and has enhanced effectiveness due to a higher antigen content. It is administered as an injection… | 70 | $70 | $4.8K |
| 99233 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 60 | $80 | $4.3K |
| 90740 | This code represents a vaccine product administered intramuscularly to protect against the liver disease hepatitis B. The vaccine has a three–dose schedule. The dosage is for patients who are… | 20 | $150 | $3.6K |
| 90739 | This code represents an adult–dosage vaccine product administered intramuscularly to protect against the liver disease hepatitis B. The product has a synthetic DNA called CpG added to improve the… | 20 | $160 | $2.8K |
| 90480 | The provider administers the first or only component of a SARS–CoV–2 (COVID–19) vaccine by intramuscular injection to reduce the patient's risk of contracting COVID–19. | 70 | $40 | $2.6K |
| G0008 | Administration of influenza virus vaccine | 80 | $30 | $2.3K |
| G0009 | Administration of pneumococcal vaccine | 50 | $30 | $1.5K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 20 | $70 | $1.5K |